AXL activation promotes adaptive resistance to KRAS-G12C inhibitors in KRASG12C-mutated non-small cell lung cancer

被引：0
作者：
Morimoto, Kenji
Yamada, Tadaaki
Hirai, Soichi
Katayama, Yuki
Kunimasa, Kei
Sasaki, Takaaki
Nishida, Makoto
Watanabe, Satoshi
Shiotsu, Shinsuke
Uehara, Hisanori
Takayama, Koichi
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1941
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1941
引用
收藏
页数：2
相关论文
共 50 条
[41]   Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer [J].
Molina-Arcas, Miriam ;
Moore, Christopher ;
Rana, Sareena ;
van Maldegem, Febe ;
Mugarza, Edurne ;
Romero-Clavijo, Pablo ;
Herbert, Eleanor ;
Horswell, Stuart ;
Li, Lian-Sheng ;
Janes, Matthew R. ;
Hancock, David C. ;
Downward, Julian .
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (510)
[42]   Development of combination therapies to potentiate the impact of KRAS-G12C inhibitors in lung cancer [J].
Molina-Arcas, Miriam ;
Moore, Christopher ;
Rana, Sareena ;
Van Maldegem, Febe ;
Mugarza, Edurne ;
Romero-Clavijo, Pablo ;
Horswell, Stuart ;
Hancock, David ;
Downward, Julian .
MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
[43]   Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRASG12C-Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review [J].
Luo, Jia ;
Florez, Narjust ;
Donnelly, Anjali ;
Lou, Yanyan ;
Lu, Kevin ;
Ma, Patrick C. ;
Spira, Alexander I. ;
Ryan, Debra ;
Husain, Hatim .
JCO PRECISION ONCOLOGY, 2024, 8
[44]   Targeting KRAS-G12C in lung cancer: The emerging role of PROTACs in overcoming resistance [J].
Chidambaram, Kumarappan ;
Rekha, A. ;
Goyal, Ahsas ;
Rana, Mohit .
PATHOLOGY RESEARCH AND PRACTICE, 2025, 270 :155954
[45]   KRAS G12C-mutant driven non-small cell lung cancer (NSCLC) [J].
Rosell, Rafael ;
Codony-Servat, Jordi ;
Gonzalez, Jessica ;
Santarpia, Mariacarmela ;
Jain, Anisha ;
Shivamallu, Chandan ;
Wang, Yu ;
Gimenez-Capitan, Ana ;
Molina-Vila, Miguel A. ;
Nilsson, Jonas ;
Gonzalez-Cao, Maria .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 195
[46]   Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12C mutation [J].
Zheng, Xinting ;
Luo, Jiamin ;
Liu, Wei ;
Ashby, Charles R., Jr. ;
Chen, Zhe-Sheng ;
Lin, Lizhu .
DRUGS OF TODAY, 2022, 58 (04) :175-185
[47]   Dissecting the Clinical Characteristics and Treatment Outcomes Correlates of KRAS G12C-Mutated Non-Small Cell Lung Cancer [J].
Jing, Yawan ;
Cheng, Ruixin ;
Zeng, Hao ;
Huang, Qin ;
He, Dongyu ;
Sun, Jiayi ;
Tian, Panwen ;
Li, Yalun .
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 :4507-4517
[48]   Early-stage KRAS G12C-mutated non-small cell lung cancer (NSCLC) in Australia. [J].
Mitchell, Paul ;
Dharmaraj, Devisri ;
Knight, Simon .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[49]   Sotorasib treatment in KRAS G12C-mutated non-small cell lung cancer: Experience in the Tours university hospital [J].
Bessy, C. ;
Blin, T. ;
Pichon, E. ;
Marchand-Adam, S. ;
Carmier, D. .
REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (01) :17-23
[50]   WEE1 inhibition enhances anti-tumor activity of sotorasib in KRASG12C-mutated non-small cell lung cancer in preclinical models [J].
Yamamoto, Gaku ;
Tanaka, Kosuke ;
Kamata, Ryo ;
Yamauchi, Toyohiro ;
Liu, Jie ;
Ohashi, Akihiro ;
Kobayashi, Susumu S. .
CANCER SCIENCE, 2023, 114 :1043-1043
12345